• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估保护哮喘患者在短期接触空气中化学物质时免受健康影响的评估因素的实验依据。

Evaluation of the experimental basis for assessment factors to protect individuals with asthma from health effects during short-term exposure to airborne chemicals.

作者信息

Johansson Mia K V, Johanson Gunnar, Öberg Mattias

机构信息

a Unit of Work Environment Toxicology , Karolinska Institutet, Institute of Environmental Medicine , Stockholm , Sweden and.

b Swedish Toxicology Sciences Research Center , Södertälje , Sweden.

出版信息

Crit Rev Toxicol. 2016;46(3):241-60. doi: 10.3109/10408444.2015.1092498. Epub 2015 Oct 29.

DOI:10.3109/10408444.2015.1092498
PMID:26515429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4819830/
Abstract

BACKGROUND

Asthmatic individuals constitute a large sub-population that is often considered particularly susceptible to the deleterious effects of inhalation of airborne chemicals. However, for most such chemicals information on asthmatics is lacking and inter-individual assessment factors (AFs) of 3-25 have been proposed for use in the derivation of health-based guideline values.

OBJECTIVE

To evaluate available information in attempt to determine whether a general difference in airway response during short-term exposure between healthy and asthmatic individuals can be identified, and whether current AFs for inter-individual variability provide sufficient protection for asthmatics.

METHODS

After performing systematic review of relevant documents and the scientific literature estimated differential response factors (EDRF) were derived as the ratio between the lowest observed adverse effect levels for healthy and asthmatic subjects based on studies in which both groups were tested under the same conditions. Thereafter, the concentration-response relationships for healthy and asthmatic subjects exposed separately to four extensively tested chemicals (nitrogen dioxide, ozone, sulfuric acid, sulfur dioxide) were compared on the basis of combined data. Finally, a Benchmark Concentration (BMC) analysis was performed for sulfur dioxide.

RESULTS

We found evidence of higher sensitivity among asthmatics (EDRF > 1) to 8 of 19 tested chemicals, and to 3 of 11 mixtures. Thereafter, we confirmed the higher sensitivity of asthmatics to sulfuric acid and sulfur dioxide. No difference was observed in the case of ozone and nitrogen dioxide. Finally, our BMC analysis of sulfur dioxide indicated a ninefold higher sensitivity among asthmatics.

CONCLUSION

Although experimental data are often inconclusive, our analyses suggest that an AF of 10 is adequate to protect asthmatics from the deleterious respiratory effects of airborne chemicals.

摘要

背景

哮喘患者是一个庞大的亚群体,常被认为特别容易受到吸入空气中化学物质的有害影响。然而,对于大多数此类化学物质,缺乏关于哮喘患者的信息,并且已经提出了3至25的个体间评估因子(AFs)用于推导基于健康的指导值。

目的

评估现有信息,试图确定能否识别出健康个体和哮喘个体在短期暴露期间气道反应的一般差异,以及当前个体间变异性的AFs是否为哮喘患者提供了足够的保护。

方法

在对相关文件和科学文献进行系统综述后,根据在相同条件下对两组进行测试的研究,将估计的差异反应因子(EDRF)推导为健康受试者和哮喘受试者的最低观察到的不良反应水平之比。此后,根据合并数据比较了分别暴露于四种经过广泛测试的化学物质(二氧化氮、臭氧、硫酸、二氧化硫)的健康受试者和哮喘受试者的浓度-反应关系。最后,对二氧化硫进行了基准浓度(BMC)分析。

结果

我们发现哮喘患者对19种测试化学物质中的8种以及11种混合物中的3种具有更高的敏感性(EDRF>1)。此后,我们证实了哮喘患者对硫酸和二氧化硫具有更高的敏感性。在臭氧和二氧化氮的情况下未观察到差异。最后,我们对二氧化硫的BMC分析表明哮喘患者的敏感性高九倍。

结论

尽管实验数据往往没有定论,但我们的分析表明,10的AF足以保护哮喘患者免受空气中化学物质的有害呼吸影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/419b7c9d6011/itxc_a_1092498_f0011_c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/54df6279e7e2/itxc_a_1092498_f0001_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/e07e79f22929/itxc_a_1092498_f0002_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/a3c82bc11cfe/itxc_a_1092498_f0003_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/22d3f4f489ec/itxc_a_1092498_f0004_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/c65a20aca9b5/itxc_a_1092498_f0005_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/2c61aeacbacc/itxc_a_1092498_f0006_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/cba992b9b212/itxc_a_1092498_f0007_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/aba19e70c97a/itxc_a_1092498_f0008_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/edf40ed99665/itxc_a_1092498_f0009_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/764cef688312/itxc_a_1092498_f0010_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/419b7c9d6011/itxc_a_1092498_f0011_c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/54df6279e7e2/itxc_a_1092498_f0001_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/e07e79f22929/itxc_a_1092498_f0002_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/a3c82bc11cfe/itxc_a_1092498_f0003_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/22d3f4f489ec/itxc_a_1092498_f0004_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/c65a20aca9b5/itxc_a_1092498_f0005_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/2c61aeacbacc/itxc_a_1092498_f0006_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/cba992b9b212/itxc_a_1092498_f0007_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/aba19e70c97a/itxc_a_1092498_f0008_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/edf40ed99665/itxc_a_1092498_f0009_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/764cef688312/itxc_a_1092498_f0010_b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/221b/4819830/419b7c9d6011/itxc_a_1092498_f0011_c.jpg

相似文献

1
Evaluation of the experimental basis for assessment factors to protect individuals with asthma from health effects during short-term exposure to airborne chemicals.评估保护哮喘患者在短期接触空气中化学物质时免受健康影响的评估因素的实验依据。
Crit Rev Toxicol. 2016;46(3):241-60. doi: 10.3109/10408444.2015.1092498. Epub 2015 Oct 29.
2
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Interventions to improve inhaler technique for people with asthma.改善哮喘患者吸入器使用技术的干预措施。
Cochrane Database Syst Rev. 2017 Mar 13;3(3):CD012286. doi: 10.1002/14651858.CD012286.pub2.
7
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
8
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Individual-level interventions to reduce personal exposure to outdoor air pollution and their effects on people with long-term respiratory conditions.个体层面的干预措施以减少个人接触室外空气污染及其对长期呼吸系统疾病患者的影响。
Cochrane Database Syst Rev. 2021 Aug 9;8(8):CD013441. doi: 10.1002/14651858.CD013441.pub2.

引用本文的文献

1
Air Pollution and Effects of Tropospheric Ozone (O) on Public Health.空气污染与对流层臭氧(O)对公众健康的影响
Int J Environ Res Public Health. 2025 Apr 30;22(5):709. doi: 10.3390/ijerph22050709.
2
Exposure limits for indoor volatile substances concerning the general population: The role of population-based differences in sensory irritation of the eyes and airways for assessment factors.室内挥发性物质暴露限值针对的是一般人群:基于人群的眼部和呼吸道感觉刺激差异在评估因素中的作用。
Arch Toxicol. 2024 Mar;98(3):617-662. doi: 10.1007/s00204-023-03642-w. Epub 2024 Jan 19.
3
Pain Perception, Brain Connectivity, and Neurochemistry in Healthy, Capsaicin-Sensitive Subjects.

本文引用的文献

1
Evaluation of adverse human lung function effects in controlled ozone exposure studies.在受控臭氧暴露研究中对人体肺功能不良影响的评估。
J Appl Toxicol. 2014 May;34(5):516-24. doi: 10.1002/jat.2905. Epub 2013 Jul 9.
2
Prediction of lung function response for populations exposed to a wide range of ozone conditions.预测暴露于大范围臭氧条件下的人群的肺功能反应。
Inhal Toxicol. 2012 Aug;24(10):619-33. doi: 10.3109/08958378.2012.705919.
3
How are asthmatics included in the derivation of guideline values for emergency planning and response?
健康、辣椒素敏感受试者的疼痛感知、大脑连通性和神经化学。
Neural Plast. 2020 Oct 28;2020:9125913. doi: 10.1155/2020/9125913. eCollection 2020.
4
Does industry take the susceptible subpopulation of asthmatic individuals into consideration when setting derived no-effect levels?行业在设定推导无效应水平时是否考虑了哮喘患者中的易感亚群?
J Appl Toxicol. 2016 Nov;36(11):1379-91. doi: 10.1002/jat.3352. Epub 2016 Jun 9.
哮喘患者如何被纳入紧急规划和响应指南值的推导中?
Regul Toxicol Pharmacol. 2012 Aug;63(3):461-70. doi: 10.1016/j.yrtph.2012.05.010. Epub 2012 Jun 7.
4
A review of controlled human SO₂ exposure studies contributing to the US EPA integrated science assessment for sulfur oxides.一项关于控制人体 SO₂ 暴露研究的综述,为美国环保署关于硫氧化物的综合科学评估做出了贡献。
Inhal Toxicol. 2011 Jan;23(1):33-43. doi: 10.3109/08958378.2010.539290.
5
Analysis of the concentration-respiratory response among asthmatics following controlled short-term exposures to sulfur dioxide.分析哮喘患者在短期受控接触二氧化硫后,浓度与呼吸反应之间的关系。
Inhal Toxicol. 2010 Dec;22(14):1184-93. doi: 10.3109/08958378.2010.535220.
6
Discrepancy among acute guideline levels for emergency response.急救指南水平的差异。
J Hazard Mater. 2010 Dec 15;184(1-3):439-447. doi: 10.1016/j.jhazmat.2010.08.054. Epub 2010 Aug 22.
7
Critical review of the human data on short-term nitrogen dioxide (NO2) exposures: evidence for NO2 no-effect levels.对短期二氧化氮(NO2)暴露的人体数据进行批判性回顾:NO2 无作用水平的证据。
Crit Rev Toxicol. 2009;39(9):743-81. doi: 10.3109/10408440903294945.
8
Meta-analysis of nitrogen dioxide exposure and airway hyper-responsiveness in asthmatics.二氧化氮暴露与哮喘患者气道高反应性的荟萃分析。
Crit Rev Toxicol. 2009;39(9):719-42. doi: 10.3109/10408440903283641.
9
Overview of the Standing Operating Procedure (SOP) for the development of Provisional Advisory Levels (PALs).暂定咨询水平(PAL)制定标准作业程序(SOP)概述。
Inhal Toxicol. 2009 Dec;21 Suppl 3:1-11. doi: 10.3109/08958370903202747.
10
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.系统评价与Meta分析优先报告条目:PRISMA声明
PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.